HER2-Low Breast Cancer Not a Unique Biological Entity, Researchers Say
There are “minimal prognostic differences” between HER2-low breast cancer and HER2-negative breast cancer, according to researchers.
news
ONA Summit Coming in March for Oncology Nurses in All Roles
The ONA Summit is to be held from March 17-19, 2023, as a virtual event of educational sessions targeted at oncology nurses in all roles. Attendees can earn 16 continuing education credit hours upon completion of the summit.
SABCS: Most Young Women With Breast Cancer Report Impact on Sexual Health
The vast majority also report their health care provider does not address sexual health issues.
Combination Venetoclax Plus Azacitidine Appears Promising in High-Risk MDS or CMML
Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with high-risk MDS or chronic myelomonocytic leukemia.
Postmastectomy Numbness: An Important Patient Discussion in Breast Cancer Care
A breast cancer survivor describes her experience with a little-discussed side effect of mastectomy.
Dialysis Population Has Excess Cancer Mortality
Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Deaths From COVID-19 Have Decreased Over Time for Cancer Patients
Over time, COVID-19 was diagnosed in younger and fitter cancer patients, and these patients were less likely to be hospitalized or die from COVID-19.
Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
A Case of Multiple Myeloma Presenting With Ophthalmic Changes
A case report describes an atypical presentation of multiple myeloma marked by immunogammopathy maculopathy and hyperviscosity syndrome-related retinopathy.
Guidance Issued for Preventing Cutaneous SCC in Solid Organ Recipients
For five of six actinic damage and skin cancer index stages, consensus-based recommendations developed
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...